Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results

BACKGROUND: The introduction of biologics has revolutionized the management of the chronic inflammatory bowel disease, ulcerative colitis (UC), with many patients experiencing significant improvements not only in their symptoms but in other outcomes relevant to individuals and society as a whole. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Teich, Niels, Grümmer, Harald, Jörgensen, Eric, Liceni, Thomas, Holtkamp-Endemann, Frank, Fischer, Tim, Hohenberger, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284175/
https://www.ncbi.nlm.nih.gov/pubmed/32550760
http://dx.doi.org/10.3748/wjg.v26.i21.2852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284175/
https://www.ncbi.nlm.nih.gov/pubmed/32550760
http://dx.doi.org/10.3748/wjg.v26.i21.2852

Ejemplares similares